A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals.


Journal

Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 17 07 2020
revised: 14 09 2020
accepted: 04 10 2020
pubmed: 10 10 2020
medline: 29 7 2021
entrez: 9 10 2020
Statut: ppublish

Résumé

Currently the only methods for non-genotoxic carcinogenic hazard assessment accepted by most regulatory authorities are lifetime carcinogenicity studies. However, these involve the use of large numbers of animals and the relevance of their predictive power and results has been scientifically challenged. With increased availability of innovative test methods and enhanced understanding of carcinogenic processes, it is believed that tumour formation can now be better predicted using mechanistic information. A workshop organised by the European Partnership on Alternative Approaches to Animal Testing brought together experts to discuss an alternative, mechanism-based approach for cancer risk assessment of agrochemicals. Data from a toolbox of test methods for detecting modes of action (MOAs) underlying non-genotoxic carcinogenicity are combined with information from subchronic toxicity studies in a weight-of-evidence approach to identify carcinogenic potential of a test substance. The workshop included interactive sessions to discuss the approach using case studies. These showed that fine-tuning is needed, to build confidence in the proposed approach, to ensure scientific correctness, and to address different regulatory needs. This novel approach was considered realistic, and its regulatory acceptance and implementation can be facilitated in the coming years through continued dialogue between all stakeholders and building confidence in alternative approaches.

Identifiants

pubmed: 33035627
pii: S0273-2300(20)30215-4
doi: 10.1016/j.yrtph.2020.104789
pii:
doi:

Substances chimiques

Agrochemicals 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104789

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Mirjam Luijten (M)

National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, Bilthoven, the Netherlands. Electronic address: mirjam.luijten@rivm.nl.

Raffaella Corvi (R)

European Commission, Joint Research Centre (JRC), Ispra, Italy.

Jyotigna Mehta (J)

ADAMA Agricultural Solutions Ltd., Reading, UK.

Marco Corvaro (M)

Corteva Agriscience, Rome, Italy.

Nathalie Delrue (N)

Organisation for Economic Cooperation and Development (OECD), Paris, France.

Susan Felter (S)

Procter & Gamble Company, Mason, OH, USA.

Bodo Haas (B)

Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany.

Nicola J Hewitt (NJ)

SWS, Wingertstrasse 25, 64390 Erzhausen, Germany.

Gina Hilton (G)

PETA International Science Consortium Ltd, London, UK.

Thomas Holmes (T)

ADAMA Deutschland GmbH, Cologne, Germany.

Miriam N Jacobs (MN)

Centre for Radiation, Chemical and Environmental Hazards (CRCE), Public Health England, UK.

Abigail Jacobs (A)

US Food and Drug Administration (now retired), MD, USA.

Franz Lamplmair (F)

European Commission, DG Internal Market, Industry, Entrepreneurship and SMEs, Brussels, Belgium.

Dick Lewis (D)

Syngenta Crop Protection, Bracknell, UK.

Federica Madia (F)

European Commission, Joint Research Centre (JRC), Ispra, Italy.

Irene Manou (I)

EPAA Industry Secretariat, Brussels, Belgium.

Stephanie Melching-Kollmuss (S)

BASF SE, Limburgerhof, Germany.

Frederic Schorsch (F)

Bayer SAS, Lyon, France.

Katrin Schütte (K)

European Commission, DG Environment, Brussels, Belgium.

Fiona Sewell (F)

National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.

Christian Strupp (C)

Gowan Crop Protection, Reading, United Kingdom.

Jan Willem van der Laan (JW)

Medicines Evaluation Board, Utrecht, the Netherlands.

Douglas C Wolf (DC)

Syngenta Crop Protection, LLC, Greensboro, North Carolina, USA.

Gerrit Wolterink (G)

National Institute for Public Health and the Environment (RIVM), Centre for Nutrition, Prevention and Health Services, Bilthoven, the Netherlands.

Ruud Woutersen (R)

TNO Innovation for Life, Zeist; Wageningen University and Research, Wageningen, the Netherlands.

Zvonimir Zvonar (Z)

EPAA Industry Secretariat, Brussels, Belgium.

Harm Heusinkveld (H)

National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, Bilthoven, the Netherlands.

Hedwig Braakhuis (H)

National Institute for Public Health and the Environment (RIVM), Centre for Health Protection, Bilthoven, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH